Skip to main content Back to Top
Advertisement

5/26/2016

Atorvastatin Tablets

Products Affected - Description

    • Atorvastatin tablet, Apotex, 10 mg, 90 count, NDC 60505-2578-09
    • Atorvastatin tablet, Apotex, 10 mg, 1000 count, NDC 60505-2578-08
    • Atorvastatin tablet, Apotex, 20 mg, 90 count, NDC 60505-2579-09
    • Atorvastatin tablet, Apotex, 20 mg, 1000 count, NDC 60505-2579-08
    • Atorvastatin tablet, Apotex, 40 mg, 90 count, NDC 60505-2580-09
    • Atorvastatin tablet, Apotex, 40 mg, 1000 count, NDC 60505-2580-08
    • Atorvastatin tablet, Apotex, 80 mg, 90 count, NDC 60505-2671-09
    • Atorvastatin tablet, Apotex, 80 mg, 1000 count, NDC 60505-2671-08
    • Atorvastatin tablet, Sandoz, 40 mg, 90 count, NDC 00781-5384-92

Reason for the Shortage

    • Ranbaxy discontinued atorvastatin in late-2014.
    • Apotex has atorvastatin tablets on allocation due to increased demand.
    • Sandoz states the shortage is due to demand exceeding supply.

Available Products

    • Lipitor tablet, Pfizer, 10 mg, 90 count, NDC 00071-0155-23
    • Lipitor tablet, Pfizer, 10 mg, 100 count, NDC 00071-0155-40
    • Lipitor tablet, Pfizer, 10 mg, 5000 count, NDC 00071-0155-34
    • Lipitor tablet, Pfizer, 20 mg, 90 count, NDC 00071-0156-23
    • Lipitor tablet, Pfizer, 20 mg, 100 count, NDC 00071-0156-40
    • Lipitor tablet, Pfizer, 20 mg, 5000 count, NDC 00071-0156-94
    • Lipitor tablet, Pfizer, 40 mg, 90 count, NDC 00071-0157-23
    • Lipitor tablet, Pfizer, 40 mg, 100 count, NDC 00071-0157-40
    • Lipitor tablet, Pfizer, 40 mg, 500 count, NDC 00071-0157-73
    • Lipitor tablet, Pfizer, 40 mg, 2500 count, NDC 00071-0157-88
    • Lipitor tablet, Pfizer, 80 mg, 64 count, NDC 00071-0158-92
    • Lipitor tablet, Pfizer, 80 mg, 90 count, NDC 00071-0158-23
    • Lipitor tablet, Pfizer, 80 mg, 500 count, NDC 00071-0158-73
    • Lipitor tablet, Pfizer, 80 mg, 2500 count, NDC 00071-0158-88
    • Atorvastatin tablet, Dr. Reddy's, 10 mg, 90 count, NDC 55111-0121-90
    • Atorvastatin tablet, Dr. Reddy's, 10 mg, 500 count, NDC 55111-0121-05
    • Atorvastatin tablet, Dr. Reddy's, 20 mg, 90 count, NDC 55111-0122-90
    • Atorvastatin tablet, Dr. Reddy's, 20 mg, 500 count, NDC 55111-0122-05
    • Atorvastatin tablet, Dr. Reddy's, 40 mg, 90 count, NDC 55111-0123-90
    • Atorvastatin tablet, Dr. Reddy's, 40 mg, 500 count, NDC 55111-0123-05
    • Atorvastatin tablet, Dr. Reddy's, 80 mg, 90 count, NDC 55111-0124-90
    • Atorvastatin tablet, Dr. Reddy's, 80 mg, 500 count, NDC 55111-0124-05
    • Atorvastatin tablet, Greenstone, 10 mg, 90 count, NDC 59762-0155-01
    • Atorvastatin tablet, Greenstone, 10 mg, 1000 count, NDC 59762-0155-02
    • Atorvastatin tablet, Greenstone, 20 mg, 90 count, NDC 59762-0156-01
    • Atorvastatin tablet, Greenstone, 20 mg, 1000 count, NDC 59762-0156-02
    • Atorvastatin tablet, Greenstone, 40 mg, 500 count, NDC 59762-0157-02
    • Atorvastatin tablet, Greenstone, 80 mg, 90 count, NDC 59762-0158-01
    • Atorvastatin tablet, Greenstone, 80 mg, 500 count, NDC 59762-0158-02
    • Atorvastatin tablet, Kremers Urban, 10 mg, 90 count, NDC 62175-0890-46
    • Atorvastatin tablet, Kremers Urban, 10 mg, 1000 count, NDC 62175-0890-43
    • Atorvastatin tablet, Kremers Urban, 20 mg, 90 count, NDC 62175-0891-46
    • Atorvastatin tablet, Kremers Urban, 20 mg, 1000 count, NDC 62175-0891-43
    • Atorvastatin tablet, Kremers Urban, 40 mg, 90 count, NDC 62175-0892-41
    • Atorvastatin tablet, Kremers Urban, 40 mg, 500 count, NDC 62175-0892-46
    • Atorvastatin tablet, Kremers Urban, 80 mg, 90 count, NDC 62175-0897-46
    • Atorvastatin tablet, Kremers Urban, 80 mg, 500 count, NDC 62175-0897-41
    • Atorvastatin tablet, Major, 10 mg, 100 count, NDC 00904-6290-61
    • Atorvastatin tablet, Major, 20 mg, 100 count, NDC 00904-6291-61
    • Atorvastatin tablet, Mylan, 10 mg, 90 count, NDC 00378-3950-77
    • Atorvastatin tablet, Mylan, 10 mg, 500 count, NDC 00378-3950-05
    • Atorvastatin tablet, Mylan, 20 mg, 90 count, NDC 00378-3951-77
    • Atorvastatin tablet, Mylan, 20 mg, 500 count, NDC 00378-3951-05
    • Atorvastatin tablet, Mylan, 40 mg, 90 count, NDC 00378-3952-77
    • Atorvastatin tablet, Mylan, 40 mg, 500 count, NDC 00378-3952-05
    • Atorvastatin tablet, Mylan, 80 mg, 90 count, NDC 00378-3953-77
    • Atorvastatin tablet, Mylan, 80 mg, 500 count, NDC 00378-3953-05
    • Atorvastatin tablet, Mylan Institutional, 10 mg, 100 count, NDC 51079-0208-20
    • Atorvastatin tablet, Mylan Institutional, 20 mg, 100 count, NDC 51079-0209-20
    • Atorvastatin tablet, Mylan Institutional, 40 mg, 100 count, NDC 51079-0210-20
    • Atorvastatin tablet, Mylan Institutional, 80 mg, 30 count, NDC 51079-0211-03
    • Atorvastatin tablet, Sandoz, 10 mg, 90 count, NDC 00781-5381-92
    • Atorvastatin tablet, Sandoz, 20 mg, 90 count, NDC 00781-5382-92
    • Atorvastatin tablet, Sandoz, 80 mg, 90 count, NDC 00781-5388-92

Estimated Resupply Dates

    • Apotex has atorvastatin tablets available to contracted customers and based on customer's forecast.
    • Sandoz has atorvastatin 40 mg tablets on back order and the company cannot estimate a release date.

Updated

Updated May 26, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 18, 2013 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT